Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Capital Expenditures (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Capital Expenditures for 16 consecutive years, with $93.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 54.21% to $93.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $571.8 million, a 17.18% decrease, with the full-year FY2025 number at $571.8 million, down 17.18% from a year prior.
  • Capital Expenditures was $93.2 million for Q4 2025 at Acadia Healthcare Company, down from $136.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $203.5 million in Q4 2024 to a low of $43.7 million in Q3 2021.
  • A 5-year average of $111.4 million and a median of $92.0 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: skyrocketed 114.07% in 2024, then tumbled 54.21% in 2025.
  • Acadia Healthcare Company's Capital Expenditures stood at $88.2 million in 2021, then fell by 0.94% to $87.4 million in 2022, then soared by 58.8% to $138.7 million in 2023, then surged by 46.69% to $203.5 million in 2024, then tumbled by 54.21% to $93.2 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Capital Expenditures are $93.2 million (Q4 2025), $136.2 million (Q3 2025), and $167.7 million (Q2 2025).